Issues

• Fluoroquinolones are becoming de facto first line antibiotics for treatment of CAP

  • 1 billion $US/year

• CAP guidelines

  • IDSA
  • Canadian
  • ATS

Previous slide

Next slide

Back to first slide

View graphic version